Sotoxen (Sotorasib) 120 MG – 56 Tablets

Generic equivalent of Sotorasib® · Manufactured by Everest Pharmaceuticals Limited
(1 customer review)

$550.00
Prices subject to change

Sotorasib (Sotoxen) is for treating adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that has a specific genetic mutation called KRAS G12C. Patients must have undergone at least one prior systemic therapy.

whatsapp_qr
Whatsapp +8801922101029